Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2017-01-09 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PANTIN (93500), Seine-Saint-Denis
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES TROIS VILLES : revenue, balance sheet and financial ratios
PHARMACIE DES TROIS VILLES is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PANTIN (93500),
this company of category PME
shows in 2023 a revenue of 3.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES TROIS VILLES (SIREN 824222889)
Indicator
2024
2024
2023
2022
2021
2019
2018
2017
Revenue
N/C
N/C
3 115 961 €
N/C
N/C
N/C
N/C
N/C
Net income
105 954 €
116 129 €
147 795 €
314 270 €
202 168 €
86 327 €
93 405 €
63 972 €
EBITDA
N/C
N/C
222 183 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
4.7%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DES TROIS VILLES generates positive net income of 106 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 64 k€ -> 106 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
105 954 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 112%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
112.315%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
36.764%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES TROIS VILLES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
2024
Debt ratio
1060.957
470.207
287.168
193.641
150.613
119.097
83.8
112.315
Financial autonomy
6.851
14.969
21.879
27.431
29.885
37.594
43.767
36.764
Repayment capacity
None
None
None
None
None
4.141
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
6.018%
None%
None%
Sector positioning
Debt ratio
112.312024
2023
2024
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE DES TROIS VILLES (112.31) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
36.76%2024
2023
2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE DES TROIS VILLES (36.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.14 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DES TROIS VILLES (4.14) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 221.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
221.151
Liquidity indicators evolution PHARMACIE DES TROIS VILLES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2023
2024
2024
Liquidity ratio
128.405
162.403
157.313
234.802
206.316
258.859
166.054
221.151
Interest coverage
None
None
None
None
None
2.229
None
None
Sector positioning
Liquidity ratio
221.152024
2023
2024
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good-9 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DES TROIS VILLES (221.15) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.23x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DES TROIS VILLES (2.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES TROIS VILLES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
235 349 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
18
0
0
Customer payment term (days)
0
0
0
0
0
10
0
0
Supplier payment term (days)
0
0
0
0
0
32
0
0
Positioning of PHARMACIE DES TROIS VILLES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES TROIS VILLES is estimated at
1 479 196 €
(range 1 030 088€ - 2 212 962€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1030k€1479k€2212k€
1 479 196 €Range: 1 030 088€ - 2 212 962€
NAF 5 année 2024
Valuation method used
Net Income Multiple
105 954 €
×
14.0x
=1 479 196 €
Range: 1 030 089€ - 2 212 962€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES TROIS VILLES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES TROIS VILLES
What is the revenue of PHARMACIE DES TROIS VILLES ?
The revenue of PHARMACIE DES TROIS VILLES in 2023 is 3.1 M€.
Is PHARMACIE DES TROIS VILLES profitable?
Yes, PHARMACIE DES TROIS VILLES generated a net profit of 106 k€ in 2024.
Where is the headquarters of PHARMACIE DES TROIS VILLES ?
The headquarters of PHARMACIE DES TROIS VILLES is located in PANTIN (93500), in the department Seine-Saint-Denis.
Where to find the tax return of PHARMACIE DES TROIS VILLES ?
The tax return of PHARMACIE DES TROIS VILLES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES TROIS VILLES operate?
PHARMACIE DES TROIS VILLES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart